Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. We believe that a healthy economy, environment and society are fundamental to long-term value creation. This is why we manage our business in accordance with the Triple Bottom Line business principle and consider the financial, environmental and social impact of our business decisions. The strategic commitment to corporate sustainability has brought the company onto centre stage as a leading player in today's business environment, recognised for its integrated reporting, stakeholder engagement and consistently high sustainability performance.
In one of the foremost assessments of corporate environmental performance, Novo Nordisk moved up 12 places to rank #15 on the 2...
Today, Novo Nordisk published a new issue of its quarterly sustainability magazine, TBL Quarterly with focus on the US. Diabetes affects 29 million people in the US and is changing the health of its citizens and putting pressure on the delivery of healthcare. Making a ...
The challenge of diabetes continues to grow in Russia where 4 million people are diagnosed and even more are unaware of their condition. A new case study shows how Novo Nordisk together with partners is addressing this challenge and outlines...
Since Novo Nordisk was founded more than 90 years ago, the company has been committed to improving the lives of people with diabetes. Nothing would change the life of a child with type 1 diabetes more than a cure for this lifelong serious condition, but is a cure just a dream – or a po...
Novo Nordisk has ranked 66 on the FORTUNE "100 Best Companies to Work For®" list, marking the seventh consecutive year Novo Nordisk has been recognized as a leading workplace. Novo Nordisk's selection underscores the passion of its employees to improv...
Anyone who has ever visited Denmark will know that bicycles are one thing the country is certainly not lacking. The sprawling Novo Nordisk sites across Denmark are no exception, where Novo Nordisk-branded bikes help employees get around between buildings throughout the day.
Novo Nordisk's 2014 Annual Report highlights the company’s progression towards long-term targets taking an integrated approach that accounts for financial, social and environmental performance. The 2014...
Today Novo Nordisk published its 2014 Annual Report detailing the company’s performance. The report highlights the company’s progression towards long-term targets taking an integrated approach ...
Today, many parts of the Middle East and North Africa struggle with conflict and civil unrest. What is perhaps less known is the threat diabetes poses, responsible for 367,700 premature deaths each year. The new issue of Novo Nordisk’...
Global research company Frost & Sullivan has named Novo Nordisk as the Diabetes CSR Company of the Year. The acknowledgement recognizes the company’s long-term commitment to improving diabetes care in Indonesia.
“As a leading diabetes care company we are committed to work closely with ...